Genflow Biosciences plc (LON:GENF – Get Free Report) was up 13% during trading on Tuesday . The stock traded as high as GBX 2.90 and last traded at GBX 2.83. Approximately 400,998 shares traded hands during trading, a decline of 85% from the average daily volume of 2,674,494 shares. The stock had previously closed at GBX 2.50.
Genflow Biosciences Stock Up 6.1%
The firm has a 50 day moving average of GBX 2.04 and a 200 day moving average of GBX 1.97. The firm has a market cap of £15.91 million, a price-to-earnings ratio of -5.92 and a beta of 2.11.
About Genflow Biosciences
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Featured Articles
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
